SG11202100240RA - A xinafoate salt of a jak inhibiting compound - Google Patents
A xinafoate salt of a jak inhibiting compoundInfo
- Publication number
- SG11202100240RA SG11202100240RA SG11202100240RA SG11202100240RA SG11202100240RA SG 11202100240R A SG11202100240R A SG 11202100240RA SG 11202100240R A SG11202100240R A SG 11202100240RA SG 11202100240R A SG11202100240R A SG 11202100240RA SG 11202100240R A SG11202100240R A SG 11202100240RA
- Authority
- SG
- Singapore
- Prior art keywords
- inhibiting compound
- xinafoate salt
- jak
- jak inhibiting
- xinafoate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862699955P | 2018-07-18 | 2018-07-18 | |
| US201962866013P | 2019-06-25 | 2019-06-25 | |
| PCT/EP2019/069252 WO2020016302A1 (en) | 2018-07-18 | 2019-07-17 | A xinafoate salt of a jak inhibiting compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202100240RA true SG11202100240RA (en) | 2021-02-25 |
Family
ID=67396927
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202100240RA SG11202100240RA (en) | 2018-07-18 | 2019-07-17 | A xinafoate salt of a jak inhibiting compound |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US11149029B2 (en) |
| EP (1) | EP3823964A1 (en) |
| JP (2) | JP7422732B2 (en) |
| KR (1) | KR20210033474A (en) |
| CN (1) | CN112424187A (en) |
| AU (1) | AU2019304014B2 (en) |
| BR (1) | BR112021000467A2 (en) |
| CA (1) | CA3105585A1 (en) |
| IL (1) | IL280025A (en) |
| MA (1) | MA53162A (en) |
| MX (1) | MX2021000611A (en) |
| SG (1) | SG11202100240RA (en) |
| WO (1) | WO2020016302A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115260128B (en) * | 2022-09-21 | 2022-12-09 | 苏州凯瑞医药科技有限公司 | Preparation method of novel JAK inhibitor key intermediate |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2452965T3 (en) | 2007-09-05 | 2014-04-03 | Rigel Pharmaceuticals, Inc. | N4 - [(2,2-Difluoro-4H-benzo [1,4] oxazin-3-one) -6-yl] -5-fluoro-N2- [3- (methylaminocarbonylmethyloxy) phenyl] -2-xinafoate salt , 4-pyrimidinediamine |
| AR082974A1 (en) * | 2010-09-15 | 2013-01-23 | Hoffmann La Roche | DERIVATIVES OF AZABENZOTIAZOL, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, METHOD TO PREPARE THEM AND USE OF THEM TO TREAT INFLAMMATORY DISEASES |
| DK3063143T3 (en) * | 2013-11-01 | 2018-08-20 | Novartis Ag | Amino heteroaryl benzamides as kinase inhibitors |
| PT3189045T (en) | 2014-08-11 | 2022-03-17 | Sun Pharmaceutical Ind Ltd | Novel salts of nilotinib and polymorphs thereof |
| EP4219482A1 (en) * | 2015-09-25 | 2023-08-02 | Dizal (Jiangsu) Pharmaceutical Co., Ltd. | Compounds and methods for inhibiting jak |
| WO2018134213A1 (en) * | 2017-01-17 | 2018-07-26 | Astrazeneca Ab | Jak1 selective inhibitors |
| CN106831538B (en) * | 2017-01-22 | 2019-06-25 | 苏州楚凯药业有限公司 | The preparation method of tropsch imatinib intermediate |
-
2019
- 2019-07-17 MX MX2021000611A patent/MX2021000611A/en unknown
- 2019-07-17 BR BR112021000467-0A patent/BR112021000467A2/en unknown
- 2019-07-17 JP JP2021502626A patent/JP7422732B2/en active Active
- 2019-07-17 AU AU2019304014A patent/AU2019304014B2/en active Active
- 2019-07-17 SG SG11202100240RA patent/SG11202100240RA/en unknown
- 2019-07-17 EP EP19742558.0A patent/EP3823964A1/en active Pending
- 2019-07-17 MA MA053162A patent/MA53162A/en unknown
- 2019-07-17 WO PCT/EP2019/069252 patent/WO2020016302A1/en active Application Filing
- 2019-07-17 KR KR1020217001860A patent/KR20210033474A/en unknown
- 2019-07-17 US US16/513,781 patent/US11149029B2/en active Active
- 2019-07-17 CN CN201980047093.4A patent/CN112424187A/en active Pending
- 2019-07-17 CA CA3105585A patent/CA3105585A1/en active Pending
-
2021
- 2021-01-07 IL IL280025A patent/IL280025A/en unknown
-
2023
- 2023-10-02 JP JP2023171327A patent/JP2024001109A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| MA53162A (en) | 2021-05-26 |
| BR112021000467A2 (en) | 2021-04-06 |
| US20200062737A1 (en) | 2020-02-27 |
| JP2021530526A (en) | 2021-11-11 |
| KR20210033474A (en) | 2021-03-26 |
| CA3105585A1 (en) | 2020-01-23 |
| JP7422732B2 (en) | 2024-01-26 |
| JP2024001109A (en) | 2024-01-09 |
| CN112424187A (en) | 2021-02-26 |
| WO2020016302A1 (en) | 2020-01-23 |
| EP3823964A1 (en) | 2021-05-26 |
| AU2019304014B2 (en) | 2022-08-18 |
| WO2020016302A8 (en) | 2020-11-12 |
| IL280025A (en) | 2021-03-01 |
| MX2021000611A (en) | 2021-04-13 |
| AU2019304014A1 (en) | 2021-03-04 |
| US11149029B2 (en) | 2021-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL281518A (en) | Process of manufacture of a compound for inhibiting the activity of shp2 | |
| EP3619208C0 (en) | Crystalline forms of a jak inhibitor compound | |
| ZA201906817B (en) | Methods of treatment using a jak inhibitor compound | |
| PT3601283T (en) | Fused imidazo-piperidine jak inhibitor compound | |
| MA43318A (en) | NEW BIPHENYL COMPOUND OR A SALT OF IT | |
| SG11202103042XA (en) | 2-azabicyclo hexane compound as jak inhibitor | |
| EP4067343A4 (en) | Novel phenol compound or salt thereof | |
| IL269626A (en) | Crystalline salt forms of boc-d-arg-dmt-lys-(boc)-phe-nh2 | |
| IL290692A (en) | Salt | |
| ZA201903885B (en) | Polymorphs of herbicidal sulfonamides | |
| IL280025A (en) | A xinafoate salt of a jak inhibiting compound | |
| FI3891156T3 (en) | New crystalline forms of a thienopyrimidine as mcl-1 inhibitor | |
| PL3717461T3 (en) | A novel isoxazole compound or a salt thereof | |
| HK1246786A1 (en) | Crystalline forms of a pyrrolopyridine compound | |
| IL276195A (en) | Salt forms of organic compound | |
| IL278054A (en) | The crystalline forms of a compound | |
| IL277578A (en) | Novel salt forms of urat-1 inhibitors | |
| GB201804905D0 (en) | Cataltic synthesis of biarylic compounds | |
| GB201809458D0 (en) | Salt form | |
| GB201809460D0 (en) | Salt form | |
| EP3315493A4 (en) | Phenyl amino pyrimidine compound or polymorph of salt thereof | |
| IL284564A (en) | Polymorphic forms of a substituted-quinoxaline-type bridged-piperidine compound | |
| GB201910664D0 (en) | Novel forms of compound | |
| ZA201707682B (en) | Polymorphs of a pges-1 inhibiting triazolone compound | |
| GB201910665D0 (en) | Novel form of compounds |